| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9895 | 
      | Human Intestinal Absorption | HIA+ | 0.9851 | 
      | Caco-2 Permeability | Caco2+ | 0.7983 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7440 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9092 | 
                                                     | Non-inhibitor | 0.9241 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9022 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5086 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8506 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8894 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6345 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.6332 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9495 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9557 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9467 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9871 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9327 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9510 | 
                                                                    | Non-inhibitor | 0.9371 | 
      | AMES Toxicity | Non AMES toxic | 0.9604 | 
      | Carcinogens | Carcinogens  | 0.5680 | 
      | Fish Toxicity | High FHMT | 0.5269 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8366 | 
      | Honey Bee Toxicity | High HBT | 0.7767 | 
      | Biodegradation | Ready biodegradable | 0.9391 | 
      | Acute Oral Toxicity | III | 0.8509 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6880 |